Related Experiment Video
Updated: May 8, 2026
04:24
A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
[DGRW-Update: Rehabilitation in Diabetes Mellitus]
1Klinik Niederrhein der Deutschen Rentenversicherung Rheinland, Bad Neuenahr-Ahrweiler. hartmut.pollmann@klinikniederrhein.de
Die Rehabilitation
|August 30, 2013
Summary
Diabetes mellitus management requires individualized therapy, not strict normoglycaemia. Early, evidence-based rehabilitation and follow-up care improve outcomes, with bariatric surgery as a new option.
Area of Science:
- Endocrinology
- Diabetology
- Rehabilitation Medicine
Context:
- Increasing prevalence and socio-medical impact of diabetes mellitus.
- Current rehabilitation practices often focus on secondary diagnoses rather than diabetes itself.
- A significant unmet need for structured rehabilitation exists among outpatients with diabetes.
Purpose:
- To advocate for individualized therapeutic goals in diabetes management, moving beyond strict normoglycaemia.
- To highlight the importance of early, evidence-based therapeutic interventions and rehabilitation for diabetes mellitus.
- To emphasize the need for improved sustainability of rehabilitation effects through integrated follow-up care.
Summary:
- Therapeutic aims for diabetes mellitus should be individualized, considering risks and benefits, as normoglycaemia is not always a feasible or primary goal.
- Numerous effective, evidence-based therapeutic modules exist for diabetes mellitus, including within rehabilitation settings, with early intervention being crucial.
- Medical rehabilitation for diabetic patients often lacks focus on diabetes itself, and there is a need to improve follow-up care and networking for long-term sustainability, with bariatric surgery emerging as a viable therapeutic option.
Impact:
- Shifting focus towards personalized diabetes care and early, comprehensive rehabilitation strategies.
- Improving the long-term effectiveness of diabetes treatment through enhanced follow-up and integrated care networks.
- Establishing bariatric surgery as a recognized and effective therapeutic intervention for select diabetic patients.
Related Concept Videos
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...